Table 5.
Selectivity of compounds for CaCYP51 (Ca) over Δ60HsCYP51 (Hs) based on K d and IC50.
Cmpd |
K d [nM] |
Selectivity |
IC50 [μM] |
Selectivity |
||
---|---|---|---|---|---|---|
|
Ca |
Hs |
Hs/Ca (fold) |
Ca |
Hs |
Hs/Ca (fold) |
5 d |
17±5 |
45±13 |
2.6 |
0.39 |
3.37 |
8.6 |
5 f |
62±17 |
74±13 |
1.2 |
0.46 |
3.73 |
8.1 |
12 c |
43±18 |
923±509 |
21.5 |
0.33 |
152 |
461 |
fluconazole |
41±13 |
38 460±4840 |
938 |
0.31 |
∼1327 |
4281 |
posaconazole |
43±11 |
204±63 |
4.7 |
0.218 |
123[a] |
615 |
voriconazole |
10±221 |
2 290±12021 |
229 |
0.218 |
78[a] |
390 |
itraconazole |
19±521 |
92±721 |
4.8 |
0.421 |
7021 |
175 |
ketoconazole |
12±321 |
42±1621 |
3.5 |
0.521 |
4.521 |
9 |
Mean K d values of three replicates are shown along with associated standard deviations. For IC50 determinations CYP51 assays contained 1 μM CaCYP51 (all azoles) or 0.25 μM Δ60HsCYP51 (5 d, 5 f, 12 c and fluconazole) or 0.4 μM Δ60HsCYP51 (posaconazole, voriconazole, itraconazole and ketoconazole). [a] See Figure S4.